Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001829126-25-006628
Filing Date
2025-08-21
Accepted
2025-08-21 17:27:21
Documents
77
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K opgeninc_10k.htm   iXBRL 10-K 1834145
2 EXHIBIT 21.1 opgeninc_ex21-1.htm EX-21.1 2512
3 EXHIBIT 23.1 opgeninc_ex23-1.htm EX-23.1 2540
4 EXHIBIT 31.1 opgeninc_ex31-1.htm EX-31.1 11673
5 EXHIBIT 32.1 opgeninc_ex32-1.htm EX-32.1 5177
  Complete submission text file 0001829126-25-006628.txt   7994332

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE opgn-20241231.xsd EX-101.SCH 68985
7 XBRL CALCULATION FILE opgn-20241231_cal.xml EX-101.CAL 64265
8 XBRL DEFINITION FILE opgn-20241231_def.xml EX-101.DEF 291739
9 XBRL LABEL FILE opgn-20241231_lab.xml EX-101.LAB 477370
10 XBRL PRESENTATION FILE opgn-20241231_pre.xml EX-101.PRE 409958
79 EXTRACTED XBRL INSTANCE DOCUMENT opgeninc_10k_htm.xml XML 1107385
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 301-869-9683
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

EIN.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37367 | Film No.: 251241744
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)